ENTPD1 and neoplasm: Extracellular adenosine exerts its immunosuppressive functions by binding to its high and low affinity receptors A2A and A2B, respectively, on immune cells.2 This sequential action of CD39 and CD73 scavenges ATP from the tumor and increases extracellular adenosine, hence generating an immunosuppressive tumor microenvironment.